1. Home
  2. PCRX vs MPB Comparison

PCRX vs MPB Comparison

Compare PCRX & MPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • MPB
  • Stock Information
  • Founded
  • PCRX 2006
  • MPB 1868
  • Country
  • PCRX United States
  • MPB United States
  • Employees
  • PCRX N/A
  • MPB N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • MPB Major Banks
  • Sector
  • PCRX Health Care
  • MPB Finance
  • Exchange
  • PCRX Nasdaq
  • MPB Nasdaq
  • Market Cap
  • PCRX 604.7M
  • MPB 525.0M
  • IPO Year
  • PCRX 2011
  • MPB N/A
  • Fundamental
  • Price
  • PCRX $22.63
  • MPB $29.96
  • Analyst Decision
  • PCRX Buy
  • MPB Buy
  • Analyst Count
  • PCRX 10
  • MPB 2
  • Target Price
  • PCRX $27.60
  • MPB $36.00
  • AVG Volume (30 Days)
  • PCRX 821.8K
  • MPB 69.6K
  • Earning Date
  • PCRX 02-27-2025
  • MPB 01-28-2025
  • Dividend Yield
  • PCRX N/A
  • MPB 2.71%
  • EPS Growth
  • PCRX N/A
  • MPB 14.41
  • EPS
  • PCRX N/A
  • MPB 2.91
  • Revenue
  • PCRX $694,957,000.00
  • MPB $173,416,000.00
  • Revenue This Year
  • PCRX $4.83
  • MPB N/A
  • Revenue Next Year
  • PCRX $2.16
  • MPB $19.26
  • P/E Ratio
  • PCRX N/A
  • MPB $10.25
  • Revenue Growth
  • PCRX 4.40
  • MPB 4.93
  • 52 Week Low
  • PCRX $11.16
  • MPB $19.20
  • 52 Week High
  • PCRX $34.01
  • MPB $33.87
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 68.73
  • MPB 55.89
  • Support Level
  • PCRX $18.18
  • MPB $28.48
  • Resistance Level
  • PCRX $23.00
  • MPB $30.00
  • Average True Range (ATR)
  • PCRX 1.16
  • MPB 0.67
  • MACD
  • PCRX 0.27
  • MPB 0.29
  • Stochastic Oscillator
  • PCRX 88.61
  • MPB 96.68

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About MPB Mid Penn Bancorp

Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.

Share on Social Networks: